Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00503_DB00543_nanopub.RA4nadCZebqB4N1a_l5buPFhuRKkSaEEcWZKTM8Zvx6bE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00503_DB00543 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00503_DB00543 label "DDI between Ritonavir and Amoxapine - Ritonavir may increase the effect and toxicity of the tricyclic antidepressant, amoxapine, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if ritonavir if initiated, discontinued or dose changed. [drugbank_resource:DB00503_DB00543]" assertion.
- drugbank_resource:DB00503_DB00543 identifier "drugbank_resource:DB00503_DB00543" assertion.
- drugbank_resource:DB00503_DB00543 title "DDI between Ritonavir and Amoxapine - Ritonavir may increase the effect and toxicity of the tricyclic antidepressant, amoxapine, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if ritonavir if initiated, discontinued or dose changed." assertion.
- drugbank:DB00503 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00503_DB00543 assertion.
- drugbank:DB00543 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00503_DB00543 assertion.